Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy.
about
Focal therapy in prostate cancer: the current situationIn vivo and in vitro evaluation of the cytotoxic effects of Photosan-loaded hollow silica nanoparticles on liver cancerEffect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy.Techniques for fluorescence detection of protoporphyrin IX in skin cancers associated with photodynamic therapy.Photodynamic therapy of cancer: an updateNew photosensitizers for photodynamic therapyFluence rate-dependent photobleaching of intratumorally administered Pc 4 does not predict tumor growth delayNoninvasive Optical Imaging of UV-Induced Squamous Cell Carcinoma in Murine Skin: Studies of Early Tumor Development and Vitamin D Enhancement of Protoporphyrin IX ProductionPDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model.Impact of treatment response metrics on photodynamic therapy planning and outcomes in a three-dimensional model of ovarian cancer.Photodynamic therapy with hexyl aminolevulinate induces carbonylation, posttranslational modifications and changed expression of proteins in cell survival and cell death pathways.Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.Correlation of in vivo tumor response and singlet oxygen luminescence detection in mTHPC-mediated photodynamic therapy
P2860
Q28242346-B0A8BCE8-070F-48F0-AD75-357E80DB040CQ33849055-C921EC17-ED53-436A-8FE6-702EA381F8ADQ34394896-6DE09FB1-85B6-4D85-B681-01FF9A2F9F63Q34972188-281144F2-B03E-41BD-AA46-4581CEB04AC6Q35532394-1D4AD4A7-4076-4895-B6F7-705DC2F47FD5Q35919257-ADCB8A70-244D-49DB-9F88-CC4C3D1AAFEEQ36201089-72860222-5657-435E-B19F-D9FEF9B021DDQ36244912-EC30D42E-D3B4-4F83-9DD9-77F3DBBC1C01Q36983114-5803DA83-1417-400B-AEE7-2DE5ED36DF83Q37197458-312F363C-8E84-46E0-A4FC-0A173C806181Q39568538-C174160A-EDD5-4567-914B-371170440CEEQ39751167-9DD3E2B6-2174-4FBB-BAD8-55056E308E95Q57699551-12D89208-F68B-48F7-A076-CAD4822A2670
P2860
Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Protoporphyrin IX fluorescence ...... vulinate photodynamic therapy.
@ast
Protoporphyrin IX fluorescence ...... vulinate photodynamic therapy.
@en
type
label
Protoporphyrin IX fluorescence ...... vulinate photodynamic therapy.
@ast
Protoporphyrin IX fluorescence ...... vulinate photodynamic therapy.
@en
prefLabel
Protoporphyrin IX fluorescence ...... vulinate photodynamic therapy.
@ast
Protoporphyrin IX fluorescence ...... vulinate photodynamic therapy.
@en
P2093
P2860
P356
P1476
Protoporphyrin IX fluorescence ...... vulinate photodynamic therapy.
@en
P2093
M O Farine
Manuel Ascencio
Pierre Collinet
P2860
P304
P356
10.1002/LSM.20629
P50
P577
2008-07-01T00:00:00Z